Scientists at the University of Oxford have developed a new method to 3D-print laboratory-grown cells to form living structures.
The approach could revolutionise regenerative medicine, enabling the production of complex tissues and cartilage that would potentially support, repair or augment diseased and damaged areas of the body.
Printing high-resolution living tissues is hard to do, as the cells often move within printed structures and can collapse on themselves. But, led by Professor Hagan Bayley, Professor of Chemical Biology in Oxford’s Department of Chemistry, the team devised a way to produce tissues in self-contained cells that support the structures to keep their shape.
The cells were contained within protective nanolitre droplets wrapped in a lipid coating that could be assembled, layer-by-layer, into living structures. Producing printed tissues in this way improves the survival rate of the individual cells, and allowed the team to improve on current techniques by building each tissue one drop at a time to a more favourable resolution.
To be useful, artificial tissues need to be able to mimic the behaviours and functions of the human body. The method enables the fabrication of patterned cellular constructs, which, once fully grown, mimic or potentially enhance natural tissues.
Dr Alexander Graham, lead author and 3D Bioprinting Scientist at OxSyBio (Oxford Synthetic Biology), said: ‘We were aiming to fabricate three-dimensional living tissues that could display the basic behaviours and physiology found in natural organisms. To date, there are limited examples of printed tissues, which have the complex cellular architecture of native tissues. Hence, we focused on designing a high-resolution cell printing platform, from relatively inexpensive components, that could be used to reproducibly produce artificial tissues with appropriate complexity from a range of cells including stem cells’.
The researchers hope that, with further development, the materials could have a wide impact on healthcare worldwide. Potential applications include shaping reproducible human tissue models that could take away the need for clinical animal testing.
Over the coming months they will work to develop new complementary printing techniques, that allow the use of a wider range of living and hybrid materials, to produce tissues at industrial scale. Dr Sam Olof, Chief Technology Officer at OxSyBio, said: ‘There are many potential applications for bioprinting and we believe it will be possible to create personalised treatments by using cells sourced from patients to mimic or enhance natural tissue function. In the future, 3D bio-printed tissues maybe also be used for diagnostic applications – for example, for drug or toxin screening.’
Learn more: A new method of 3D printing living tissues
The Latest on: Regenerative medicine
- $9 million grant funds trial of CAR T-cell therapy for metastatic breast canceron August 25, 2019 at 5:11 am
California Institute for Regenerative Medicine awarded a $9.28 million grant will support a clinical trial at City of Hope to evaluate chimeric antigen receptor T-cell therapy for patients with ...
- Stanford, Johns Hopkins cancer researchers share Albany Prizeon August 24, 2019 at 4:03 am
Weissman, MD, will both receive this year’s award in recognition of their research in stem cell and cancer cell biology that have led to advances in oncology, immunology, cancer genomics and ...
- Construction Equipment Operator's Bum Knee "Just Perfect" After Stem Cell Therapy Provided by Kansas Regenerative Medicine Centeron August 22, 2019 at 12:08 am
Orthopedic surgeon insisted that knee replacement surgery was the only way to fix construction equipment operator's bad knee. Stem cell treatment using a patient's own stem cells improved the bad knee ...
- Richard Kim Medicine Uses Patients' Blood and Stem Cells to Treat Chronic Painon August 19, 2019 at 6:02 am
Advances in Regenerative Medicine Key to Patients' Return to Pain-Free, Active Lifestyle SARATOGA SPRINGS, N.Y., Aug. 19, 2019 /PRNewswire/ -- Richard Kim, M.D., of Richard Kim Medicine in ...
- Regenerative Medicine Market Size, Share, Trends, Growth and Forecast, 2019 – 2026on August 19, 2019 at 3:14 am
Aug 19, 2019 (Global QYResearch via COMTEX) -- The report analyzes and forecasts the Regenerative medicine market at global and regional levels. The market has been forecast based on volume (Tons) and ...
- Relaxing of regulations for regenerative medicines has cascading effect internationallyon August 15, 2019 at 11:03 am
Regenerative medicine focuses on developing therapies to regenerate or replace injured, diseased or defective cells, tissues or organs, like stem cell 'treatments'. Due to the use of living cells ...
- Multi-foci laser microfabrication of 3D polymeric scaffolds for stem cell expansion in regenerative medicineon August 14, 2019 at 10:45 am
High quality large scale fabrication of cellular scaffolds, with three-dimensional resolution comparable to cell size, is an important task to enable regenerative medicine applications with stem cells ...
- Pursuing a Path of Regulatory Rigor: Taking Medtech, Regenerative Medicine to the Next Levelon August 14, 2019 at 7:35 am
The medical device industry is facing a generational change in the regulation and validation of its products.
- Regenerative Medicine Market Stand Out as the Biggest Contributor to Global Growth and Will Hit 26.1% CAGR By 2026on August 13, 2019 at 11:13 pm
Aug 14, 2019 (The Expresswire) -- Regenerative Medicine Market, conveys rigorous analysis of Industry and prospects to 2026 Fortune Business Insights states that the market will reach US$ 151,949.5 Mn ...
- Fledgling Steps toward Regenerative Medicine Superpowerson August 13, 2019 at 9:09 am
“Why can’t we be more like salamanders,” said no one ever, except perhaps a regenerative medicine scientist. As the only larger vertebrate that can regenerate entire new limbs, these slithery, slimy ...
via Google News and Bing News